Abstract

Introduction: Sestrin1, 2, and 3 are a family of stress-response proteins implicated in many diseases. How Sestrins affect cell survival through AMP-activated kinase (AMPK) and protein synthesis through mechanistic target of rapamycin in complex 1 (mTORC1) is most studied; however, how Sestrins affect metabolism is poorly understood. Hypothesis: Independent of AMPK/mTORC1 activation, Sestrins negatively regulate glycolytic flux by inhibiting glycolytic enzyme activity through binding inhibition. Results: Wildtype (WT) HEK293T cells were transfected with plasmids expressing individual FLAG-tagged Sestrins and then deprived of glucose for 180 min or deprived of glucose for 150 min followed by glucose addback for 30 min. FLAG-tagged Sestrins were immunoprecipitated and found to directly interact with Hexokinase2 and Phosphofructokinase such that binding inversely correlates with glucose concentration. Additionally, WT and Sestrin-knockout (TKO) HEK293T cells were subjected to the glycolytic and mitochondrial stress tests and analyzed for metabolic flux via Seahorse analysis. TKO cells demonstrated higher glycolytic flux, but lower mitochondrial flux, compared to WT cells. Cells were then treated with inhibitors against AMPK and mTORC1 and subjected to the glycolytic stress test. Surprisingly, glycolytic flux in TKO cells was unaffected by the inhibitors while WT cells reduced glycolytic flux suggesting Sestrins can regulate glycolytic flux independent of AMPK/mTORC1 activation. Thereafter, WT and TKO cells were glucose-deprived for 120 min or glucose-deprived for 110 min followed by glucose addback for 10 min and then characterized by steady-state metabolomics. As expected, TKO cells possessed elevations in glycolytic metabolites with glucose addback compared to WT cells. Similarly, WT and TKO cells were deprived of glucose for 110 min followed by stable isotope tracing with [13C6]glucose for 10- and 30-minutes and metabolites were profiled by mass spectrometry. TKO cells possessed higher abundances of glycolytic metabolites as well as elevated labeled extracellular lactate. Conclusions: These data support a model wherein Sestrins directly act as negative regulators for glycolytic enzyme activity, thus regulating glycolytic flux. This work is funded by F32DK126312 (P.A.R.), P30DK048520 Pilot and Feasibility Award (P.A.R.), T32DK120521 (A.E.L.), P30CA046934 Cancer Center Support Grant, R01AR080051 (A.B.), R01DK015658 (S.R.K.), P30DK048520 (P.S.M.). This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call